Last 12 months
Inside the activity.
2 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2025 Filed Jan 22, 2025 23:02 UTC |
Ahmed NabeelChief Financial Officer
|
GrantCommon Stock | 13,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000022 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,157 F1 · shares: On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:34 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 20,492 | $0.81 | $16,598.52 |
DisclosureSEC source: 0001484612-25-000014 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,028 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:36 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 15,011 | $0.81 | $12,158.91 |
DisclosureSEC source: 0001484612-25-000015 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,291 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:51 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 33,227 | $0.81 | $26,913.87 |
DisclosureSEC source: 0001484612-25-000016 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 861,397 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 70,826 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:32 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 29,031 | $0.81 | $23,515.11 |
DisclosureSEC source: 0001484612-25-000013 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,901 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 45,328 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:26 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 1,572 | $1.29 | $2,027.88 |
DisclosureSEC source: 0001484612-25-000006 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,520 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,530 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:32 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 10,227 | $1.29 | $13,192.83 |
DisclosureSEC source: 0001484612-25-000008 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 894,624 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 22,469 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:28 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 720 | $1.29 | $928.80 |
DisclosureSEC source: 0001484612-25-000007 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,302 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,581 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:24 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 1,835 | $1.29 | $2,367.15 |
DisclosureSEC source: 0001484612-25-000005 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,932 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,952 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:45 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 3,203 | $0.80 | $2,562.40 |
DisclosureSEC source: 0001484612-24-000072 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,092 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,888 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:49 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 5,645 | $0.80 | $4,516.00 |
DisclosureSEC source: 0001484612-24-000074 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 904,851 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,740 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:48 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 1,375 | $0.80 | $1,100.00 |
DisclosureSEC source: 0001484612-24-000073 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,022 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,584 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:44 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 4,221 | $0.80 | $3,376.80 |
DisclosureSEC source: 0001484612-24-000071 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,767 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 23:59 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 3,011 | $0.84 | $2,529.24 |
DisclosureSEC source: 0001484612-24-000064 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,295 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 00:02 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 5,308 | $0.84 | $4,458.72 |
DisclosureSEC source: 0001484612-24-000066 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 910,496 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,740 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 00:01 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 1,293 | $0.84 | $1,086.12 |
DisclosureSEC source: 0001484612-24-000065 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,397 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,584 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 23:57 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 3,971 | $0.84 | $3,335.64 |
DisclosureSEC source: 0001484612-24-000063 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,988 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| July 24, 2024 Filed Jul 24, 2024 23:08 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 723 | $4.02 | $2,906.46 |
DisclosureSEC source: 0000905148-24-001998 · form4.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,690 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,999 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:17 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 10,569 | $4.78 | $50,519.82 |
DisclosureSEC source: 0001484612-24-000058 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,306 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $4.77 - $4.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 22:57 UTC |
GROSSMAN D KEITHDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 38,117 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001484612-24-000057 · edgardoc.xml · derivative · entry 7 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,117 shares Expires 2024-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023. F3 · derivative.exercise_date: This option vested 25% on April 15, 2015 and then in 36 equal monthly installments thereafter. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 22:57 UTC |
GROSSMAN D KEITHDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 31,186 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001484612-24-000057 · edgardoc.xml · derivative · entry 6 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,117 Underlying: Common Stock · 31,186 shares Expires 2024-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023. F3 · derivative.exercise_date: This option vested 25% on April 15, 2015 and then in 36 equal monthly installments thereafter. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 22:57 UTC |
GROSSMAN D KEITHDirector
|
SaleCommon Stock | 11,887 | $3.74 | $44,468.08 |
DisclosureSEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 4 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,035 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $3.66-$3.83. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 22:57 UTC |
GROSSMAN D KEITHDirector
|
Exercise / conversionCommon Stock | 38,117 | $1.11 | $42,309.87 |
DisclosureSEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 3 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 22:57 UTC |
GROSSMAN D KEITHDirector
|
SaleCommon Stock | 26,230 | $3.80 | $99,765.81 |
DisclosureSEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 2 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,805 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $3.66-$3.83. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2024 Filed Jun 3, 2024 22:57 UTC |
GROSSMAN D KEITHDirector
|
Exercise / conversionCommon Stock | 31,186 | $1.11 | $34,616.46 |
DisclosureSEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023. Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:17 UTC |
Saia Andrea LynnDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000056 · edgardoc.xml · nonDerivative · entry 1 Saia Andrea Lynn · CIK 0001552993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,892 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:16 UTC |
LANG BRENT D.Director
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000055 · edgardoc.xml · nonDerivative · entry 1 LANG BRENT D. · CIK 0001544336 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,024 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:15 UTC |
JONES DALE EDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000054 · edgardoc.xml · nonDerivative · entry 1 JONES DALE E · CIK 0001261562 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,918 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:11 UTC |
Hinrichs James F.Director
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000053 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,349 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:06 UTC |
GROSSMAN D KEITHDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000051 · edgardoc.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,849 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:05 UTC |
Drexler KarenDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000050 · edgardoc.xml · nonDerivative · entry 1 Drexler Karen · CIK 0001504699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,232 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:10 UTC |
HACKETT PATRICK TDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000052 · edgardoc.xml · nonDerivative · entry 1 HACKETT PATRICK T · CIK 0001238606 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,849 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:36 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 2,972 | $3.53 | $10,491.16 |
DisclosureSEC source: 0001484612-24-000047 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,875 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:40 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 3,918 | $3.53 | $13,830.54 |
DisclosureSEC source: 0001484612-24-000049 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,959 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:38 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 1,097 | $3.53 | $3,872.41 |
DisclosureSEC source: 0001484612-24-000048 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,413 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,084 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:25 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 5,237 | $3.53 | $18,486.61 |
DisclosureSEC source: 0001484612-24-000046 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915,804 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,739 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| May 10, 2024 Filed May 10, 2024 22:19 UTC |
Racine Jean-OlivierChief Technology Officer
|
SaleCommon Stock | 8,306 | $3.27 | $27,160.62 |
DisclosureSEC source: 0001484612-24-000041 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,325 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 22:40 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 2,391 | $2.13 | $5,092.83 |
DisclosureSEC source: 0001484612-24-000039 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,510 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,399 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:56 UTC |
LANG BRENT D.Director
|
GrantCommon Stock | 108,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000037 · edgardoc.xml · nonDerivative · entry 1 LANG BRENT D. · CIK 0001544336 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,024 F1 · shares: Represents Restricted Stock Units ("RSUs") granted to the reporting person on March 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:34 UTC |
Ahmed NabeelChief Financial Officer
|
SaleCommon Stock | 1,584 | $3.15 | $4,989.60 |
DisclosureSEC source: 0001484612-24-000036 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 322,877 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:34 UTC |
Ahmed NabeelChief Financial Officer
|
OtherCommon Stock | 1,584 | $2.68 | $4,245.12 |
DisclosureSEC source: 0001484612-24-000036 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 324,461 F1 · balance_after: Includes 1,584 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:05 UTC |
Ahmed NabeelChief Financial Officer
|
Tax withholdingCommon Stock | 10,639 | $3.72 | $39,577.08 |
DisclosureSEC source: 0001484612-24-000035 · edgardoc.xml · nonDerivative · entry 2 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,877 F2 · shares: Required number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs on February 23, 2024 described in footnote (1) above. This transaction does not represent a sale or discretionary trade by the reporting person. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:05 UTC |
Ahmed NabeelChief Financial Officer
|
GrantCommon Stock | 20,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000035 · edgardoc.xml · nonDerivative · entry 1 Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,516 F1 · shares: Represents restricted stock units (RSUs) granted to the reporting person on February 23, 2024 in lieu of 50% of the reporting person's 2023 annual cash bonus amount at the request of the reporting person. The RSUs were fully vested on the grant date. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:04 UTC |
Trigg LeslieDirector · Chair and CEO
|
Tax withholdingCommon Stock | 45,538 | $3.72 | $169,401.36 |
DisclosureSEC source: 0001484612-24-000034 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 919,240 F2 · shares: Required number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs on February 23, 2024 described in footnote (1) above. This transaction does not represent a sale or discretionary trade by the reporting person. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:04 UTC |
Trigg LeslieDirector · Chair and CEO
|
GrantCommon Stock | 131,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000034 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 964,778 F1 · shares: Represents restricted stock units (RSUs) granted to the reporting person on February 23, 2024 in lieu of 100% of the reporting person's 2023 annual cash bonus amount at the request of the reporting person. The RSUs were fully vested on the grant date. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:26 UTC |
Brottem John L.General Counsel
|
SaleCommon Stock | 3,341 | $3.57 | $11,927.37 |
DisclosureSEC source: 0001484612-24-000028 · edgardoc.xml · nonDerivative · entry 1 Brottem John L. · CIK 0001823381 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,046 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,891 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:31 UTC |
Williamson Steven S.Chief Commercial Officer
|
SaleCommon Stock | 2,500 | $3.57 | $8,925.00 |
DisclosureSEC source: 0001484612-24-000032 · edgardoc.xml · nonDerivative · entry 1 Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,347 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,677 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:29 UTC |
Trigg LeslieDirector · Chair and CEO
|
SaleCommon Stock | 5,320 | $3.57 | $18,992.40 |
DisclosureSEC source: 0001484612-24-000031 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 833,091 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,748 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:28 UTC |
Racine Jean-OlivierChief Technology Officer
|
SaleCommon Stock | 1,866 | $3.57 | $6,661.62 |
DisclosureSEC source: 0001484612-24-000030 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,830 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,210 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:27 UTC |
Nash MarcSVP Operations and R&D
|
SaleCommon Stock | 617 | $3.57 | $2,202.69 |
DisclosureSEC source: 0001484612-24-000029 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,100 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,484 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021 and March 15, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.